Figan Acemoglu

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Novartis (Switzerland)21.9%
• Bayer (United States)7.7%
• Al-Azhar University7.7%
• Merck & Co., Inc., Rahway, NJ, USA (United States)7.5%
• Novartis Institutes for BioMedical Research6.9%
• Biohaven Pharmaceuticals (United States)6.4%
• Other41.9%

Fields

• Biochemistry, Genetics and Molecular Biology40.2%
• Medicine33.7%
• Chemistry12%
• Computer Science9.8%
• Immunology and Microbiology2.2%
• Materials Science1.1%
• Other1.1%

Topics

• Angiogenesis and VEGF in Cancer16.2%
• HER2/EGFR in Cancer Research10.3%
• Computational Drug Discovery Methods9.6%
• HIV/AIDS drug development and treatment9.6%
• HIV Research and Treatment7.4%
• Chemical Synthesis and Analysis5.9%
• Other41.2%